Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detection of Apolipoprotein D (ApoD) in Human Serum as Marker of Parkinson's Disease

NCT01467960 is registered in ClinicalTrials.gov with Privatklinik Villa Melitta as lead sponsor.

NCT NCT01467960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01467960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detection of Apolipoprotein D (ApoD) in Human Serum as Marker of Parkinson's Disease
Lead sponsor
Privatklinik Villa Melitta
Phase
Observational
Overall status
Unknown status
Start date
November 30, 2011
Completion date
November 30, 2013
Enrollment
180 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's